Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Virology

• Publication date

  1994-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.1994.1675PMID 7975254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

  1994cited by this paper
• Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

  1993cited by this paper
• The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.

  1993cited by this paper
• Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation

  1993cited by this paper
• Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.

  1993cited by this paper
• Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

  1993cited by this paper
• Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter

  1992cited by this paper
• Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro

  1992cited by this paper
• Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes

  1992cited by this paper
• EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus

  1991cited by this paper
• Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

  1991cited by this paper
• Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation

  1990cited by this paper
• The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

  1990cited by this paper
• Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1

  1990cited by this paper
• Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6.

  1990cited by this paper
• Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

  1990cited by this paper
• Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins.

  1990cited by this paper
• Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

  1989cited by this paper
• The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

  1988cited by this paper
• BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

  1988cited by this paper
• A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes

  1988cited by this paper
• A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes

  1988cited by this paper
• Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.

  1988cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• CR2 ligands modulate human B cell activation.

  1988cited by this paper
• Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector

  1987cited by this paper
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

  1987cited by this paper
• Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.

  1987cited by this paper
• Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.

  1986cited by this paper
• Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.

  1986cited by this paper
• The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein.

  1985cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper
• Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.

  1985cited by this paper
• Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.

  1985cited by this paper
• Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line

  1980cited by this paper
• Baculovirus structural polypeptides.

  1978cited by this paper

• Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations

  2024cites this paper
• Integrated pan-cancer map of EBV-associated neoplasms reveals functional host-virus interactions.

  2019cites this paper
• Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression

  2016cites this paper
• The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.

  2015cites this paper
• Viral-encoded genes and cancer

  2012cites this paper
• Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family

  2009cites this paper
• Functional Analysis and Characterization of Epstein Barr Virus Latent Membrane Protein 2b

  2008cites this paper
• Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C.

  2006cites this paper
• Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter

  2006cites this paper
• Regulation of Matrix Metalloproteinase 9 Expression by Epstein-Barr Virus Nuclear Antigen 3C and the Suppressor of Metastasis Nm23-H1

  2005cites this paper
• CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation

  2004cites this paper
• Biophysical and Mutational Analysis of the Putative bZIP Domain of Epstein-Barr Virus EBNA 3C

  2004cites this paper
• Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis.

  2004cites this paper
• Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis

  2004cites this paper
• Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines

  2003cites this paper
• Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses

  2003cites this paper
• Epstein-Barr Virus Nuclear Antigen 2 Binds via Its Methylated Arginine-Glycine Repeat to the Survival Motor Neuron Protein

  2003cites this paper
• The Metastatic Suppressor Nm23-H1 Interacts with EBNA3C at Sequences Located between the Glutamine- and Proline-Rich Domains and Can Cooperate in Activation of Transcription

  2002cites this paper
• Conserved Region CR2 of Epstein-Barr Virus Nuclear Antigen Leader Protein Is a Multifunctional Domain That Mediates Self-Association as well as Nuclear Localization and Nuclear Matrix Association

  2002cites this paper
• The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration.

  2002cites this paper
• Antibodies for detecting EBV latent proteins.

  2001cites this paper
• Epstein-Barr Virus Nuclear Protein 2 Has at Least Two N-Terminal Domains That Mediate Self-Association

  2001cites this paper
• Epstein-Barr Virus Nuclear Antigen 3C Activates the Latent Membrane Protein 1 Promoter in the Presence of Epstein-Barr Virus Nuclear Antigen 2 through Sequences Encompassing an Spi-1/Spi-B Binding Site

  2000cites this paper
• Mechanisms of action of Epstein-Barr virus nuclear antigen-1 as an oncogene.

  2000cites this paper
• Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex.

  1999cites this paper
• Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21

  1997influential citation
• Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.

  1996cites this paper
• Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family.

  1996cites this paper
• A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa

  1996cites this paper
• Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA

  1996cites this paper
• Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA

  1996cites this paper
• Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.

  1996cites this paper
• Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator

  1995cites this paper
• RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.

  1995cites this paper
• Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation

  1994cites this paper
• The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains

  1994cites this paper
• Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes

  1994cites this paper
• Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1

  1993cites this paper
• Epstein-Barr Virus Nuclear Protein

  year unknowncites this paper